T1	PROC 62 86	tratamiento antitusígeno
T2	CHEM 88 103	anticolinérgico
#1	AnnotatorNotes T2	C0242896; Anticholinergic Agents; Pharmacologic Substance
T3	DISO 151 167	bronquitis aguda
#2	AnnotatorNotes T3	C0149514; Acute bronchitis; Disease or Syndrome
T4	DISO 220 236	Bronquitis aguda
#3	AnnotatorNotes T4	C0149514; Acute bronchitis; Disease or Syndrome
T5	DISO 241 244	tos
#4	AnnotatorNotes T5	C0010200; Coughing; Sign or Symptom
T6	DISO 271 274	Tos
#5	AnnotatorNotes T6	C0010200; Coughing; Sign or Symptom
T7	DISO 297 313	bronquitis aguda
#6	AnnotatorNotes T7	C0149514; Acute bronchitis; Disease or Syndrome
T8	DISO 416 419	tos
#7	AnnotatorNotes T8	C0010200; Coughing; Sign or Symptom
T9	DISO 475 491	bronquitis aguda
#8	AnnotatorNotes T9	C0149514; Acute bronchitis; Disease or Syndrome
T10	PROC 523 537	ensayo clínico
#9	AnnotatorNotes T10	C0008976; Clinical Trials; Research Activity
T11	DISO 569 572	tos
#10	AnnotatorNotes T11	C0010200; Coughing; Sign or Symptom
T12	DISO 666 674	neumonía
#11	AnnotatorNotes T12	C0032285; Pneumonia; Disease or Syndrome
T13	PROC 705 728	derivación hospitalaria
T14	DISO 755 778	Enfermedad respiratoria
#12	AnnotatorNotes T14	C0035204; Respiration Disorders; Disease or Syndrome
T15	PROC 394 411	atención primaria
#13	AnnotatorNotes T15	C0033137; Primary Health Care; Health Care Activity
T16	DISO 788 827	enfermedad pulmonar obstructiva crónica
#14	AnnotatorNotes T16	C0024117; Chronic Obstructive Airway Disease; Disease or Syndrome
T17	DISO 829 833	asma
#15	AnnotatorNotes T17	C0004096; Asthma; Disease or Syndrome
T18	DISO 835 847	tuberculosis
#16	AnnotatorNotes T18	C0041296; Tuberculosis; Disease or Syndrome
T19	DISO 850 865	bronquiectasias
#17	AnnotatorNotes T19	C0006267; Bronchiectasis; Disease or Syndrome
T20	DISO 869 881	Comorbilidad
#18	AnnotatorNotes T20	C1275743; Co-morbid conditions; Finding
T21	DISO 906 928	insuficiencia cardíaca
#19	AnnotatorNotes T21	C0018801; Heart failure; Disease or Syndrome
T22	DISO 945 953	demencia
#20	AnnotatorNotes T22	C0497327; Dementia; Mental or Behavioral Dysfunction
T23	DISO 955 981	infarto agudo de miocardio
#21	AnnotatorNotes T23	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T24	DISO 984 1011	accidente vascular cerebral
#22	AnnotatorNotes T24	C0038454; Cerebrovascular accident; Disease or Syndrome
T25	DISO 1033 1055	insuficiencia hepática
#23	AnnotatorNotes T25	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
T26	DISO 1064 1083	insuficiencia renal
#24	AnnotatorNotes T26	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T27	PROC 1094 1109	Inmunosupresión
#25	AnnotatorNotes T27	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T28	DISO 1114 1123	Neoplasia
#26	AnnotatorNotes T28	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T29	DISO 1133 1152	Enfermedad terminal
T30	DISO 1167 1179	intolerancia
#27	AnnotatorNotes T30	C0277585; Intolerance to drug; Pathologic Function
T31	DISO 1182 1189	alergia
#28	AnnotatorNotes T31	C1527304; Allergic Reaction; Pathologic Function
T32	PROC 1206 1218	tratamientos
#29	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	PROC 1305 1316	tratamiento
#30	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	CHEM 1338 1359	bromuro de ipratropio
#31	AnnotatorNotes T34	C0700580; ipratropium bromide; Organic Chemical · Pharmacologic Substance
T35	PROC 1433 1467	visitas programadas de seguimiento
#32	AnnotatorNotes T35	C0589121; Follow-up visit; Health Care Activity
T36	CHEM 74 86	antitusígeno
#33	AnnotatorNotes T36	C0003449; Antitussive Agents; Pharmacologic Substance
T37	ANAT 799 807	pulmonar
#34	AnnotatorNotes T37	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T38	ANAT 920 928	cardíaca
#35	AnnotatorNotes T38	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T39	ANAT 972 981	miocardio
#36	AnnotatorNotes T39	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T40	ANAT 994 1002	vascular
#37	AnnotatorNotes T40	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C0042591; Vessel Positions; Body Location or Region
T41	ANAT 1003 1011	cerebral
#38	AnnotatorNotes T41	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T42	ANAT 1047 1055	hepática
#39	AnnotatorNotes T42	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T43	ANAT 1078 1083	renal
#40	AnnotatorNotes T43	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T44	CHEM 1321 1336	dextrometorfano
#41	AnnotatorNotes T44	C0011816; dextromethorphan; Organic Chemical · Pharmacologic Substance
T45	Date 13 17	2018
T46	LIVB 139 146	adultos
#42	AnnotatorNotes T46	C0001675; Adult; Age Group
T49	Duration 423 439	máximo 3 semanas
T50	LIVB 541 550	Pacientes
#43	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Time 573 579	diurna
#44	AnnotatorNotes T51	C0332169; Daytime; Temporal Concept
T52	Time 584 592	nocturna
#45	AnnotatorNotes T52	C0240526; Night time; Temporal Concept
T53	Spec_cue 654 665	Sospecha de
T54	LIVB 679 687	Paciente
#46	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	PHYS 731 739	Embarazo
#47	AnnotatorNotes T55	C0032961; Pregnancy; Organism Function
T56	PHYS 742 751	lactancia
#48	AnnotatorNotes T56	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T57	Duration 820 827	crónica
#49	AnnotatorNotes T57	C0205191; chronic; Temporal Concept
T58	Date 1012 1020	reciente
T59	LIVB 1233 1242	Pacientes
#50	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 1268 1280	investigador
#51	AnnotatorNotes T60	C0035173; Research Personnel; Professional or Occupational Group
T61	LIVB 1371 1400	Pacientes institucionalizados
#52	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group + C0376326; Institutionalized Persons; Patient or Disabled Group
T62	ANAT 766 778	respiratoria
#53	AnnotatorNotes T62	C0035237; Respiratory System; Body System | C1269561; Entire respiratory system; Body System
T47	Age 355 368	18 años o más
T48	CHEM 106 110	miel
#54	AnnotatorNotes T48	C0939937; honey preparation; Organic Chemical · Pharmacologic Substance
T64	LIVB 342 351	Pacientes
#55	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Duration 1022 1030	<3 meses
T63	CHEM 1362 1366	miel
#56	AnnotatorNotes T63	C0939937; honey preparation; Organic Chemical · Pharmacologic Substance
T66	PROC 1381 1400	institucionalizados
#57	AnnotatorNotes T66	C0021629; Institutionalization; Health Care Activity
A1	Assertion T12 Speculated
A2	Population_data T46 Age
A3	Status T24 History_of
A4	Status T23 History_of
A5	Status T31 History_of
A6	Status T30 History_of
A7	Assertion T33 Contraindicated
A8	Assertion T44 Contraindicated
A9	Assertion T34 Contraindicated
A10	Assertion T63 Contraindicated
#58	AnnotatorNotes T1	C1096670; Antitussive therapy; Therapeutic or Preventive Procedure 
#59	AnnotatorNotes T13	C0019982; Hospital Referral; Health Care Activity 
#60	AnnotatorNotes T29	C0679247; Terminal illness; Disease or Syndrome
#61	AnnotatorNotes T58	C0332185; Recent; Temporal Concept
T67	Neg_cue 168 170	no
T68	Quantifier_or_Qualifier 171 181	complicada
A11	Assertion T68 Negated
#62	AnnotatorNotes T68	C0231242; Complicated; Functional Concept
R1	Used_for Arg1:T36 Arg2:T1	
R2	Experiences Arg1:T46 Arg2:T1	
R3	Experiences Arg1:T46 Arg2:T2	
R4	Experiences Arg1:T46 Arg2:T48	
R5	Experiences Arg1:T46 Arg2:T3	
R6	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T68	
R7	Negation Arg1:T67 Arg2:T68	
R8	Overlap Arg1:T4 Arg2:T5	
R9	Overlap Arg1:T6 Arg2:T7	
R10	Has_Age Arg1:T64 Arg2:T47	
R11	Experiences Arg1:T64 Arg2:T15	
R12	Experiences Arg1:T64 Arg2:T8	
R13	Has_Duration_or_Interval Arg1:T8 Arg2:T49	
R14	Overlap Arg1:T8 Arg2:T9	
R15	Experiences Arg1:T64 Arg2:T9	
T69	Observation 498 516	acepten participar
R16	Before Arg1:T69 Arg2:T10	
T70	Quantifier_or_Qualifier 563 565	≥4
T71	CONC 599 612	escala Likert
#64	AnnotatorNotes T71	C0451267; Likert scale; Intellectual Product
R20	Has_Quantifier_or_Qualifier Arg1:T71 Arg2:T70	
R21	Experiences Arg1:T50 Arg2:T11	
R22	Overlap Arg1:T11 Arg2:T51	
R23	Overlap Arg1:T11 Arg2:T52	
R24	Speculation Arg1:T53 Arg2:T12	
R25	Experiences Arg1:T54 Arg2:T13	
R26	Location_of Arg1:T62 Arg2:T14	
R27	Location_of Arg1:T37 Arg2:T16	
R28	Has_Duration_or_Interval Arg1:T16 Arg2:T57	
R29	Location_of Arg1:T62 Arg2:T17	
R30	Location_of Arg1:T62 Arg2:T18	
R31	Location_of Arg1:T62 Arg2:T19	
R32	Location_of Arg1:T38 Arg2:T21	
R33	Location_of Arg1:T40 Arg2:T24	
R34	Location_of Arg1:T41 Arg2:T24	
R35	Location_of Arg1:T39 Arg2:T23	
R36	Overlap Arg1:T24 Arg2:T58	
R37	Has_Duration_or_Interval Arg1:T24 Arg2:T65	
R38	Location_of Arg1:T42 Arg2:T25	
R39	Location_of Arg1:T43 Arg2:T26	
T72	Quantifier_or_Qualifier 882 895	significativa
#65	AnnotatorNotes T72	C1546944; Event Seriousness - Significant; Qualitative Concept
R40	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T72	
T73	Quantifier_or_Qualifier 1056 1062	severa
#66	AnnotatorNotes T73	C1547227; Severe - Severity of Illness Code; Intellectual Product
R41	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T73	
T74	Quantifier_or_Qualifier 1084 1090	severa
#67	AnnotatorNotes T74	C1547227; Severe - Severity of Illness Code; Intellectual Product
R42	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T74	
T75	Quantifier_or_Qualifier 929 943	moderada-grave
#68	AnnotatorNotes T75	C1299393; Moderate to severe; Qualitative Concept
R43	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T75	
R44	Causes Arg1:T32 Arg2:T31	
R45	Causes Arg1:T32 Arg2:T30	
T76	Quantifier_or_Qualifier 1124 1130	activa
#69	AnnotatorNotes T76	C0679217; Active State; Idea or Concept
R46	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T76	
R47	Used_for Arg1:T44 Arg2:T33	
R48	Used_for Arg1:T34 Arg2:T33	
R49	Used_for Arg1:T63 Arg2:T33	
R51	Experiences Arg1:T61 Arg2:T66	
T77	Observation 1404 1467	Dificultad para realizar las visitas programadas de seguimiento
#63	AnnotatorNotes T69	C1302239; Patient consented to clinical trial; Finding
A12	Experiencer T60 Other
A13	Experiencer T59 Patient
A14	Experiencer T61 Patient
A15	Experiencer T46 Patient
A16	Experiencer T64 Patient
A17	Experiencer T50 Patient
A18	Experiencer T54 Patient
